Inclusion of KV CBCT Dose in the Patient Treatment Plans and Evaluation of Dose to Normal Tissue and Critical Organs
Byline
P Alaei1 *, E Spezi2 , P Downes2 , R Jarvis2 , E Radu2 , M Reynolds1 , (1) University of Minnesota, Minneapolis, MN, (2) Velindre Cancer Centre, Cardiff , Wales, GB,